William Guyer
Chief Development Officer at Corcept Therapeutics Inc (CORT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 12SEC | CORTCorcept Therapeutics Inc | Sell Plan | 11,5308,755 held (−57%) | $113.18 | $1.3M | +7.1% |
| Aug 12SEC | CORTCorcept Therapeutics Inc | Sell Plan | 4,7703,985 held (−54%) | $114.04 | $544K | +6.3% |
| Aug 6SEC | CORTCorcept Therapeutics Inc | Sell Plan | 3,7003,985 held (−48%) | $113.12 | $419K | +7.1% |
| Jul 8SEC | CORTCorcept Therapeutics Inc | Sell Plan | 19,0484,937 held (−79%) | $93.11 | $1.8M | +30.2% |
| Jul 8SEC | CORTCorcept Therapeutics Inc | Sell Plan | 9523,985 held (−19%) | $93.54 | $89K | +29.6% |
| Jun 4SEC | CORTCorcept Therapeutics Inc | Sell Plan | 20,0003,985 held (−83%) | $70.60 | $1.4M | +71.7% |
| May 7SEC | CORTCorcept Therapeutics Inc | Sell Plan | 20,0002,231 held (−90%) | $51.83 | $1.0M | +133.8% |
| Apr 8SEC | CORTCorcept Therapeutics Inc | Sell Plan | 20,0002,231 held (−90%) | $40.97 | $819K | +195.8% |
| Mar 24SEC | CORTCorcept Therapeutics Inc | Sell Plan | 11,7672,231 held (−84%) | $36.01 | $424K | +236.5% |
| Mar 6SEC | CORTCorcept Therapeutics Inc | Sell Plan | 8,2332,231 held (−79%) | $35.99 | $296K | +236.7% |
| Feb 5SEC | CORTCorcept Therapeutics Inc | Sell Plan | 20,0001,235 held (−94%) | $40.87 | $817K | +196.5% |
| Jan 8SEC | CORTCorcept Therapeutics Inc | Sell Plan | 20,0001,235 held (−94%) | $35.18 | $704K | +244.5% |
| Dec 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 19,3601,875 held (−91%) | $80.05 | $1.5M | +51.4% |
| Dec 3SEC | CORTCorcept Therapeutics Inc | Sell Plan | 6401,235 held (−34%) | $80.88 | $52K | +49.8% |
| Dec 3SEC | CORTCorcept Therapeutics Inc | Sell | 4,500787 held (−85%) | $80.90 | $364K | +49.8% |
| Nov 26SEC | CORTCorcept Therapeutics Inc | Sell | 4,500787 held (−85%) | $80.90 | $364K | +49.8% |
| Nov 7SEC | CORTCorcept Therapeutics Inc | Sell Plan | 6,53618,751 held (−26%) | $74.75 | $489K | +62.1% |
| Nov 7SEC | CORTCorcept Therapeutics Inc | Sell Plan | 13,1645,587 held (−70%) | $75.64 | $996K | +60.2% |
| Nov 7SEC | CORTCorcept Therapeutics Inc | Sell Plan | 3005,287 held (−5%) | $76.28 | $23K | +58.9% |
| Oct 9SEC | CORTCorcept Therapeutics Inc | Sell Plan | 20,0005,287 held (−79%) | $89.94 | $1.8M | +34.7% |
- Sell
Chief Development Officer William Guyer sold $1.3M of CORT at $113.18 — cuts the stake by 57%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer William Guyer sold $544K of CORT at $114.04 — cuts the stake by 54%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer William Guyer sold $419K of CORT at $113.12 — cuts the stake by 48%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer William Guyer sold $1.8M of CORT at $93.11 — cuts the stake by 79%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer William Guyer sold $89K of CORT at $93.54 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Development Officer William Guyer sold $1.4M of CORT at $70.60 — cuts the stake by 83%; pre-scheduled 10b5-1 plan sale.